Disease-modifying therapies in relapsing–remitting multiple sclerosis

CLINICAL QUESTION: What is the best current disease-modifying therapy for relapsing–remitting multiple sclerosis? RESULTS: The evidence shows that the most effective disease-modifying therapy for delaying short- to medium-term disability progression, prevention of relapses, reducing the area and act...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Andrade, Fabricio, Alcaraz-Alvarez, José Luis
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Evidence 2 Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938285/
https://www.ncbi.nlm.nih.gov/pubmed/20856600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938285/
https://www.ncbi.nlm.nih.gov/pubmed/20856600

Ejemplares similares